Source: World Intellectual Property Organization (WIPO) Handbook on Industrial Property Information and Documentation, Standard ST.25: Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings in Patent Applications (2009).
| Symbol
| Meaning
|
|---|
| ac4c | 4-acetylcytidine.
|
| chm5u | 5-(carboxyhydroxymethyl)uridine.
|
| cm | 2′-O-methylcytidine.
|
| cmnm5s2u | 5-carboxymethylaminomethyl-2-thiouridine.
|
| cmnm5u | 5-carboxymethylaminomethyluridine.
|
| d | dihydrouridine.
|
| fm | 2′-O-methylpseudouridine.
|
| gal q | beta, D-galactosylqueuosine.
|
| gm | 2′-O-methylguanosine.
|
| i | inosine.
|
| i6a | N6-isopentenyladenosine.
|
| m1a | 1-methyladenosine.
|
| m1f | 1-methylpseudouridine.
|
| m1g | 1-methylguanosine.
|
| m1i | 1-methylinosine.
|
| m22g | 2,2-dimethylguanosine.
|
| m2a | 2-methyladenosine.
|
| m2g | 2-methylguanosine.
|
| m3c | 3-methylcytidine.
|
| m5c | 5-methylcytidine.
|
| m6a | N6-methyladenosine.
|
| m7g | 7-methylguanosine.
|
| mam5u | 5-methylaminomethyluridine.
|
| mam5s2u | 5-methoxyaminomethyl-2-thiouridine.
|
| man q | beta, D-mannosylqueuosine.
|
| mcm5s2u | 5-methoxycarbonylmethyl-2-thiouridine.
|
| mcm5u | 5-methoxycarbonylmethyluridine.
|
| mo5u | 5-methoxyuridine.
|
| ms2i6a | 2-methylthio-N6-isopentenyladenosine.
|
| ms2t6a | N-((9-beta-D-ribofuranosyl-2-methylthiopurine-6-yl)carbamoyl)threonine.
|
| mt6a | N-((9-beta-D-ribofuranosylpurine-6-yl)N-methylcarbamoyl)threonine.
|
| mv | uridine-5-oxyacetic acid-methylester.
|
| o5u | uridine-5-oxyacetic acid.
|
| osyw | wybutoxosine.
|
| p | pseudouridine.
|
| q | queuosine.
|
| s2c | 2-thiocytidine.
|
| s2t | 5-methyl-2-thiouridine.
|
| s2u | 2-thiouridine.
|
| s4u | 4-thiouridine.
|
| t | 5-methyluridine.
|
| t6a | N-((9-beta-D-ribofuranosylpurine-6-yl)-carbamoyl)threonine.
|
| tm | 2′-O-methyl-5-methyluridine.
|
| um | 2′-O-methyluridine.
|
| yw | wybutosine.
|
| x | 3-(3-amino-3-carboxy-propyl)uridine, (acp3)u. |
[86 FR 57052, Oct. 14, 2021]
source: 24 FR 10332, Dec. 22, 1959, unless otherwise noted.